Endocrinology
- Profound xanthomas in a young man
The patient had a history of type 2 diabetes mellitus, hypercholesterolemia, and hypertriglyceridemia, with a fasting serum triglyceride level of 9,000 mg/dL.
- Xanthomas: A clue to undiagnosed lipid disorders
Given the wide availability of direct-to-consumer laboratory testing, it is reasonable to ask whether a working knowledge of xanthomas still matters for trainees and clinicians.
- Update on antiobesity pharmacotherapy in adults: Current and emerging options
The authors review antiobesity medications that are currently available or under investigation and discuss how to personalize obesity treatment.
- Diabetes: Putting off until tomorrow what could happen today can be good
Prevention of beta-cell loss and preservation of endogenous insulin production have been attractive treatment prerogatives in type 1 diabetes.
- How can I select the right thyroid hormone formulation for my patient with hypothyroidism?
Knowing the features of the available thyroid hormone formulations can provide a starting point for individualizing therapy for patients who have concerns about product formulations or remain symptomatic despite a normal thyroid-stimulating hormone level.
Finding the cause of severe hypokalemia: A 4-step approachThis case illustrates the approach to a group of conditions associated with hypokalemia that usually pose a diagnostic challenge.
- Latent autoimmune diabetes in adults: Not type 1, not type 2, a little of both
Latent autoimmune diabetes in adults shares features of type 1 and type 2 diabetes, often leading to misdiagnosis and a delay in starting needed insulin therapy.
- LADA: A case for starting insulin therapy at diagnosis
The author discusses factors that support starting insulin therapy at diagnosis in all patients with latent autoimmune diabetes in adults.
